BTW
CRL icon

Boston Trust Walden’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$34.2M Buy
225,191
+19,789
+10% +$3M 0.24% 153
2025
Q1
$30.9M Buy
205,402
+919
+0.4% +$138K 0.23% 158
2024
Q4
$37.7M Buy
204,483
+8,338
+4% +$1.54M 0.26% 146
2024
Q3
$38.6M Sell
196,145
-4,169
-2% -$821K 0.27% 146
2024
Q2
$41.4M Buy
200,314
+5,375
+3% +$1.11M 0.31% 130
2024
Q1
$52.8M Sell
194,939
-2,420
-1% -$656K 0.38% 108
2023
Q4
$46.7M Buy
197,359
+6,462
+3% +$1.53M 0.35% 107
2023
Q3
$37.4M Buy
190,897
+869
+0.5% +$170K 0.31% 112
2023
Q2
$40M Buy
190,028
+15,746
+9% +$3.31M 0.33% 113
2023
Q1
$35.2M Buy
174,282
+33,693
+24% +$6.8M 0.3% 124
2022
Q4
$30.6M Buy
140,589
+40,316
+40% +$8.78M 0.27% 134
2022
Q3
$19.7M Sell
100,273
-840
-0.8% -$165K 0.2% 165
2022
Q2
$21.6M Buy
101,113
+2,211
+2% +$473K 0.2% 160
2022
Q1
$28.1M Buy
98,902
+14,431
+17% +$4.1M 0.23% 150
2021
Q4
$31.8M Buy
84,471
+849
+1% +$320K 0.26% 136
2021
Q3
$34.5M Sell
83,622
-2,059
-2% -$850K 0.31% 119
2021
Q2
$31.7M Buy
85,681
+9,899
+13% +$3.66M 0.28% 127
2021
Q1
$22M Buy
75,782
+10,839
+17% +$3.14M 0.21% 155
2020
Q4
$16.2M Buy
64,943
+1,804
+3% +$451K 0.17% 172
2020
Q3
$14.3M Buy
63,139
+989
+2% +$224K 0.18% 166
2020
Q2
$10.8M Sell
62,150
-42,207
-40% -$7.36M 0.15% 191
2020
Q1
$13.2M Sell
104,357
-42,185
-29% -$5.32M 0.21% 147
2019
Q4
$22.4M Buy
146,542
+1,791
+1% +$274K 0.26% 121
2019
Q3
$19.2M Buy
144,751
+1,491
+1% +$197K 0.24% 130
2019
Q2
$20.3M Sell
143,260
-1,480
-1% -$210K 0.26% 115
2019
Q1
$21M Buy
144,740
+2,563
+2% +$372K 0.29% 108
2018
Q4
$16.1M Sell
142,177
-7,136
-5% -$808K 0.26% 111
2018
Q3
$20.1M Sell
149,313
-5,814
-4% -$782K 0.28% 110
2018
Q2
$17.4M Buy
155,127
+41,134
+36% +$4.62M 0.26% 123
2018
Q1
$12.2M Sell
113,993
-8,543
-7% -$912K 0.18% 157
2017
Q4
$13.4M Buy
+122,536
New +$13.4M 0.2% 150